Health Industry

  1. Is It Wrong To Ignore This Chance For 3D Systems?

    It was painful to invest in 3D Systems last year. The stock has been cut in half ...
  2. Is Exelixis Under-the-Radar Growth?

    Exelixis was the worst-performing biotech company, with its shares collapsing after ...
  3. Is Arena Pharmaceuticals In Trouble?

    Arena Pharmaceuticals' approval of its weight-loss drug Belviq in 2012 has brought ...
  4. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
  5. Should You Invest In Oraganovo Holdings?

    Despite the commercial launch of its bio-printed liver assays last year, Organovo ...
  6. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  1. Is It Wrong To Ignore This Chance For 3D Systems?

    It was painful to invest in 3D Systems last year. The stock has been cut in half ...
  2. Is Exelixis Under-the-Radar Growth?

    Exelixis was the worst-performing biotech company, with its shares collapsing after ...
  3. Is Arena Pharmaceuticals In Trouble?

    Arena Pharmaceuticals' approval of its weight-loss drug Belviq in 2012 has brought ...
  4. What’s The Drug That Will Finally Fight Obesity?

    Orexigen just pulled back the curtain on interim results for a cardiac study that ...
  5. Should You Invest In Oraganovo Holdings?

    Despite the commercial launch of its bio-printed liver assays last year, Organovo ...
  6. What Could Be The Outcome For Opko Health?

    Investors have pinned high hopes on Opko Health , a development-stage healthcare ...
  1. What is revenue cycle management?

    Learn more about revenue cycle management and why the healthcare industry in particular has adopted this payment process ...
  2. What is happening during a risk repricing?

    During a strong bull market, the market's overall sense of optimism can often lead to poor estimates about the level of risk ...
Trading Center